Vanessa Johnston
Pain Medicine · Eugene, ORNPI 1639647449
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 40 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by AbbVie at 32.8% of the total. That places this record below the midpoint for pain medicine clinicians in OR, where the typical reported total is $2,180.
Across 40 payments — averaging $29.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$389
- Pfizer$216
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$186
- Averitas Pharma Inc.$114
- Tonix Medicines, Inc.$84
- Collegium Pharmaceutical, Inc.$56
- plus $141 from 5 others
What the payments were for
- Food & beverage$1,187100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 19 | $389 |
| Pfizer | 5 | $216 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $186 |
| Averitas Pharma Inc. | 3 | $114 |
| Tonix Medicines, Inc. | 1 | $84 |
| Collegium Pharmaceutical, Inc. | 3 | $56 |
| GRT US Holding, Inc. | 1 | $45 |
| Biodelivery Sciences International, Inc. | 2 | $34 |
| Abbott | 1 | $25 |
| Impel Pharmaceuticals Inc. | 1 | $23 |
| Amgen | 1 | $14 |
How this compares
$1,187 in reported general payments places this provider in the 35th percentile of 57 pain medicine providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 131 | $18,981 |
| Buprenorphine Hcl | 236 | $9,797 |
| OxycontinOxycodone Hcl | 20 | $9,251 |
| Buprenorphine | 34 | $9,045 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 218 | $6,944 |
| MovantikNaloxegol Oxalate | 13 | $6,018 |
| Oxycodone Hcl | 317 | $5,576 |
| Morphine Sulfate ErMorphine Sulfate | 105 | $4,165 |
| Oxymorphone Hcl ErOxymorphone Hcl | 13 | $2,967 |
| Gabapentin | 160 | $2,851 |
| Morphine Sulfate | 100 | $2,809 |
| Fentanyl | 26 | $1,856 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 71 | $1,646 |
| Duloxetine Hcl | 51 | $1,549 |
| Zolmitriptan | 14 | $1,121 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Eugene
- Adam KempEugene$28K
- Majaliwa MzombweEugene$7K
- Mordechai BronnerEugene$2K
- Steven SurrettEugene$2K
- James MorrisEugene$866
- Michael HaberEugene$527
- Raymond RayEugene$21
- Vishal KhemlaniTualatin$338K
- Robert HerosTualatin$299K
- Joseph SavinoMedford$95K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.